IDiyas

For the Inventor, By the Inventor

Toledo, Spain

José Manuel Bartolomé-Nebreda

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Bargas, ES (2006 - 2008)
  • Toleda, ES (2013)
  • Toledo, ES (2008 - 2017)

Company Filing History:

goldMedal16 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents
silverMedal8 out of 1,153 
 
Vanderbilt University
 patents
bronzeMedal1 out of 1 
 
Beerse Pharmaceutica Nv
 patent

Years Active: 2006-2017

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents
1. 9550784 - Inhibitors of phosphodiesterase 10 enzyme (2017-01-24),
2. 9422296 - Fast-dissociating dopamine 2 receptor antagonists (2016-08-23),
3. 9255103 - Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators (2016-02-09),
4. 9090632 - Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors (2015-07-28),
5. 9040707 - Bicyclic thiazoles as allosteric modulators of mGluR5 receptors (2015-05-26),
6. 9029366 - Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors (2015-05-12),
7. 8933101 - Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists (2015-01-13),
8. 8906921 - 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists (2014-12-09),
9. 8901125 - Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors (2014-12-02),
10. 8895562 - Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists (2014-11-25),
11. 8865725 - Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors (2014-10-21),
12. 8859543 - Imidazo[1,2-a]pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases (2014-10-14),
13. 8853237 - Naphthyridinone analogs as mGluR5 positive allosteric modulators (2014-10-07),
14. 8791120 - Fast-dissociating dopamine 2 receptor antagonists (2014-07-29),
15. 8716282 - Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors (2014-05-06),

Title: Inventor José Manuel Bartolomé-Nebreda

Introduction: José Manuel Bartolomé-Nebreda is a renowned inventor hailing from Toledo, Spain, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: José Manuel Bartolomé-Nebreda holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices.

Career Highlights: Throughout his career, José Manuel Bartolomé-Nebreda has been recognized for his innovative solutions that have significantly impacted industries such as clean energy, biotechnology, and healthcare. His dedication to pushing the boundaries of traditional thinking has led to the development of cutting-edge products that have improved the quality of life for many.

Collaborations: José Manuel Bartolomé-Nebreda has collaborated with leading research institutions, universities, and companies worldwide to further his inventions and bring them to market. His ability to work across disciplines and cultures has resulted in successful partnerships that have accelerated the pace of innovation in various sectors.

Conclusion: In conclusion, José Manuel Bartolomé-Nebreda's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of inventors to think boldly and create solutions that shape the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…